Live feed
Filing
SC 13G/A
SC 13G/A0001319244-17-000003·INTEGRATED CORE STRATEGIES (US) LLC
Schedule 13G ownership disclosure
Vanda Pharmaceuticals Inc
Security class unavailable · CUSIP: 921659108
Event date: 2016-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 1.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001319244-17-000003
- Form type
- SC 13G/A
- Filer
- INTEGRATED CORE STRATEGIES (US) LLC
- CIK
- CIK 1319244
- Filed
- Jan 12, 2017
- Reporting period
- Dec 31, 2016
- Description
- Schedule 13G beneficial ownership